Peptide News Digest

#Ted-Lieu

1 story

Regulatory · View digest

Rep. Ted Lieu (D-CA) Press Conference (June 24): Suggests Trump Canceled 21st Century ROAD to Housing Bill Signing Because Receiving 'Experimental Drug for Terminal Illness'; White House Communications Director Steven Cheung Calls Lieu 'Dumba--' in Response

California Rep. Ted Lieu (D) held a press conference on June 24, 2026 suggesting that President Trump canceled the signing of the bipartisan 21st Century ROAD to Housing bill earlier that day because he is fighting a terminal illness and dealing with side effects from an experimental drug. Lieu pointed to the STAT News retatrutide compassionate-use report and reasoned that compassionate-use access typically requires terminal illness. Lieu cited Trump being 'unable to stay awake at meetings, having visible arm weakness, and swelling in his hands' as supporting observations. White House Communications Director Steven Cheung responded by calling Lieu a 'dumba--' for the suggestion. The exchange escalated the political dimension of the retatrutide story from White House versus reporter (Kush Desai vs Lizzy Lawrence on June 23-24) to House Democrat versus White House Communications Director. The 21st Century ROAD to Housing Act is a bipartisan housing reform bill that Trump was scheduled to sign on Wednesday June 24, 2026, with the signing canceled the same day. The White House has not provided a public explanation for the cancellation beyond denying any connection to the retatrutide story.